BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/12/2014 11:15:00 AM | Browse: 839 | Download: 836
Publication Name World Journal of Pharmacology
Manuscript ID 12895
Country Italy
Received
2014-07-29 10:07
Peer-Review Started
2014-07-30 12:04
To Make the First Decision
2014-09-16 10:49
Return for Revision
2014-09-18 11:52
Revised
2014-10-01 20:34
Second Decision
2014-10-29 18:02
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-10-29 18:57
Articles in Press
2014-10-29 18:57
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-11-28 17:54
Publish the Manuscript Online
2014-12-12 11:14
ISSN 2220-3192 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Review
Article Title Telomerase activity: An attractive target for cancer therapeutics
Manuscript Source Invited Manuscript
All Author List Lucia Picariello, Cecilia Grappone, Simone Polvani and Andrea Galli
Funding Agency and Grant Number
Corresponding Author Andrea Galli, MD, PhD, Professor, Gastroenterology Unit, Department of Experimental and Clinical Biomedical Sciences, University of Florence, Viale Pieraccini n°6, 50139 Florence, Italy. andrea.galli@unifi.it
Key Words Human telomerase reverse transcriptase; Immunotherapy; Suicide gene therapy; Acycloguanosyl 5’-thymidyltriphosphate; Telomerase inhibition
Core Tip One of the hallmark of cancer is the replicative immortality of tumor cells guaranteed by telomerase activity that counteracts progressive telomere shortening during cellular replication: this makes telomerase a tumor marker and a target for anticancer drugs. In this review we summarize and update the most recent innovative studies and results on the different strategies that consider telomerase as a target for cancer therapy. In particular, we try to point out the advantages and the potentialities of some innovative approaches, compared to other, equally promising, but that need further investigations.
Publish Date 2014-12-12 11:14
Citation Picariello L, Grappone C, Polvani S, Galli A. Telomerase activity: An attractive target for cancer therapeutics. World J Pharmacol 2014; 3(4): 86-96
URL http://www.wjgnet.com/2220-3192/full/v3/i4/86.htm
DOI http://dx.doi.org/10.5497/wjp.v3.i4.86
Full Article (PDF) WJP-3-86.pdf
Full Article (Word) WJP-3-86.doc
Manuscript File 12895-Review.doc
Answering Reviewers 12895-Answering reviewers.pdf
Copyright License Agreement 12895-Copyright assignment.pdf
Peer-review Report 12895-Peer review(s).pdf
Scientific Misconduct Check 12895-CrossCheck.jpg
Scientific Editor Work List 12895-Scientific editor work list.pdf